Two-Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD (Q58971166)
Jump to navigation
Jump to search
scientific article published on 01 December 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Two-Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD |
scientific article published on 01 December 2007 |
Statements
Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD (English)
E Michael Lewiecki
Paul D Miller
Michael A Bolognese
Yu Liu
Andrea Wang
Suresh Siddhanti
Lorraine A Fitzpatrick
AMG 162 Bone Loss Study Group
1 December 2007
1 reference